Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$21.5 million.

  • Aspen Aerogels' Cash from Financing Activities fell 19717.93% to -$21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year decrease of 6772.82%. This contributed to the annual value of $122.0 million for FY2024, which is 6166.25% up from last year.
  • As of Q3 2025, Aspen Aerogels' Cash from Financing Activities stood at -$21.5 million, which was down 19717.93% from -$7.6 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Cash from Financing Activities registered a high of $262.9 million during Q4 2022, and its lowest value of -$21.5 million during Q3 2025.
  • For the 5-year period, Aspen Aerogels' Cash from Financing Activities averaged around $37.8 million, with its median value being $4.9 million (2022).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 3605804.68% in 2022, then tumbled by 50838.56% in 2025.
  • Quarter analysis of 5 years shows Aspen Aerogels' Cash from Financing Activities stood at $727000.0 in 2021, then surged by 36058.05% to $262.9 million in 2022, then crashed by 71.25% to $75.6 million in 2023, then grew by 14.41% to $86.5 million in 2024, then plummeted by 124.91% to -$21.5 million in 2025.
  • Its last three reported values are -$21.5 million in Q3 2025, -$7.6 million for Q2 2025, and -$21.5 million during Q1 2025.